Can you provide the last earnings date for MAINZ BIOMED NV?
MAINZ BIOMED NV (QUCY) last reported earnings on 3/30/2026.
NASDAQ:QUCY • NL0015000LC2
Past quarterly earnings results for MAINZ BIOMED NV (QUCY), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | -2.45 | - | 76.00% | 286.7K | - | -44.95% | ||
| Q1 2025 | -2.86 | - | 77.42% | 306K | - | 20.00% | ||
| Q4 2024 | -3.67 | - | 61.75% | 373.2K | 306K | 21.96% | 73.74% | |
| Q3 2024 | -4.49 | - | 71.23% | 306K | - | 68.41% | ||
| Q2 2024 | -10.20 | - | 54.46% | 520.8K | 306K | 70.20% | 108.32% | |
| Q1 2024 | -12.65 | - | -2,710.67% | 255K | - | 2.00% | ||
| Q4 2023 | -9.60 | -12.92 | 25.70% | 48.85% | 214.8K | 275.4K | -22.00% | 16.99% |
| Q3 2023 | -15.60 | -19.31 | 19.22% | 11.08% | 181.7K | 338.303K | -46.29% | -8.65% |
| Q2 2023 | -22.40 | -17.14 | -30.72% | -19.35% | 250K | 299.197K | -16.44% | 63.40% |
| Q1 2023 | -0.45 | -0.44 | -3.40% | 97.75% | 250K | 374.003K | -33.16% | 133.43% |
| Q4 2022 | -18.77 | - | - | 183.6K | - | - | ||
| Q3 2022 | -17.54 | - | - | 198.9K | - | - | ||
| Q2 2022 | -18.77 | - | - | 153K | - | - | ||
| Q1 2022 | -19.99 | - | - | 107.1K | - | - | ||
| Q4 2021 | - | - | - | - | ||||
| Q2 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - |
Notes
MAINZ BIOMED NV (QUCY) last reported earnings on 3/30/2026.
MAINZ BIOMED NV (QUCY) missed EPS estimates and missed revenue estimates in the most recent quarter.